{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:45:45Z","timestamp":1782798345238,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejmech.2024.116417","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T01:46:34Z","timestamp":1713231994000},"page":"116417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Discovery of novel diaryl substituted isoquinolin-1(2H)-one derivatives as hypoxia-inducible factor-1 signaling inhibitors for the treatment of rheumatoid arthritis"],"prefix":"10.1016","volume":"271","author":[{"given":"Li","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Fei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Xing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ling","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Qin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Chao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2438-8068","authenticated-orcid":false,"given":"Ming-Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116417_bib1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116417_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res."},{"key":"10.1016\/j.ejmech.2024.116417_bib3","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1002\/jcp.27860","article-title":"Strategies toward rheumatoid arthritis therapy; the old and the new","volume":"234","author":"Abbasi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejmech.2024.116417_bib4","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116417_bib5","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","article-title":"Novel treatment strategies in rheumatoid arthritis","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116417_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fphar.2016.00184","article-title":"Hypoxia-inducible factor (HIF) as a target for novel therapies in rheumatoid arthritis","volume":"7","author":"Hua","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116417_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrrheum.2011.205","article-title":"Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis","volume":"8","author":"Konisti","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ejmech.2024.116417_bib8","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116417_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10456-015-9477-2","article-title":"The pathogenic role of angiogenesis in rheumatoid arthritis","volume":"18","author":"Elshabrawy","year":"2015","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ejmech.2024.116417_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar2568","article-title":"Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis","volume":"11","author":"Muz","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejmech.2024.116417_bib11","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/rheumatology\/ken086","article-title":"Role of hypoxia-inducible factor-1alpha in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes","volume":"47","author":"Ahn","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejmech.2024.116417_bib12","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.omtn.2020.01.014","article-title":"Downregulation of hypoxia-inducible factor-1\u03b1 by RNA interference alleviates the development of collagen-induced arthritis in rats","volume":"19","author":"Hu","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2024.116417_bib13","first-page":"945","article-title":"Hypoxia inducible factor-1-alpha (HIF-1alpha) is related to both angiogenesis and inflammation in rheumatoid arthritis","volume":"27","author":"Brouwer","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.ejmech.2024.116417_bib14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jconrel.2022.01.029","article-title":"CaP-based anti-inflammatory HIF-1alpha siRNA-encapsulating nanoparticle for rheumatoid arthritis therapy","volume":"343","author":"Liu","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2024.116417_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108467","article-title":"AMSP-30 m as a novel HIF-1alpha inhibitor attenuates the development and severity of adjuvant-induced arthritis in rats: impacts on synovial apoptosis, synovial angiogenesis and sonic hedgehog signaling pathway","volume":"103","author":"Meng","year":"2022","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2024.116417_bib16","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s10753-023-01878-3","article-title":"Novel HIF-1\u03b1 inhibitor AMSP-30m mitigates the pathogenic cellular behaviors of hypoxia-stimulated fibroblast-like synoviocytes and alleviates collagen-induced arthritis in rats via inhibiting sonic hedgehog pathway","volume":"46","author":"Cai","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.ejmech.2024.116417_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s43440-021-00348-7","article-title":"Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders","volume":"74","author":"Lu","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2024.116417_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.685556","article-title":"Novel isoquinoline alkaloid litcubanine A - a potential anti-inflammatory candidate","volume":"12","author":"Xia","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2024.116417_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113839","article-title":"Plant isoquinoline alkaloids: advances in the chemistry and biology of berberine","volume":"226","author":"Singh","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116417_bib20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s11684-019-0724-6","article-title":"Biological properties and clinical applications of berberine","volume":"14","author":"Song","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.ejmech.2024.116417_bib21","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1039\/D3MD00248A","article-title":"Diversely functionalized isoquinolines and their core-embedded heterocyclic frameworks: a privileged scaffold for medicinal chemistry","volume":"14","author":"Vijayakumar","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116417_bib22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cyto.2014.04.006","article-title":"Poly(ADP-ribose) polymerase-1 inhibitor modulates T regulatory and IL-17 cells in the prevention of adjuvant induced arthritis in mice model","volume":"68","author":"Ahmad","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.ejmech.2024.116417_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001071","article-title":"Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 response","volume":"2","author":"Gonzalez-Rey","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116417_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/jpet.111.187740","article-title":"RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents","volume":"341","author":"Xu","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116417_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105265","article-title":"CuCl(2)-catalyzed inexpensive, faster and ligand\/additive free synthesis of isoquinolin-1(2H)-one derivatives via the coupling-cyclization strategy: evaluation of a new class of compounds as potential PDE4 inhibitors","volume":"115","author":"Thirupataiah","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116417_bib26","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.1021\/acs.jmedchem.9b01313","article-title":"Discovery of novel aryl carboxamide derivatives as hypoxia-inducible factor 1\u03b1 signaling inhibitors with potent activities of anticancer metastasis","volume":"62","author":"Liu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116417_bib27","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1021\/acssuschemeng.7b02442","article-title":"Engineering, Fast, base-free and aqueous synthesis of quinolin-2 (1H)-ones under ambient conditions","volume":"5","author":"Xie","year":"2017","journal-title":"ACS Sustainable Chem. Eng."},{"key":"10.1016\/j.ejmech.2024.116417_bib28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ejmech.2024.116417_bib29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/1756-185X.12280","article-title":"The potential role of angiogenic factors in rheumatoid arthritis","volume":"17","author":"Azizi","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2024.116417_bib30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2011.04.020","article-title":"Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?","volume":"10","author":"Marrelli","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejmech.2024.116417_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejmech.2015.09.033","article-title":"Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1\u03b1 (HIF-1\u03b1) inhibitors","volume":"104","author":"Kim","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116417_bib32","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1016\/j.bmc.2016.09.067","article-title":"Synthesis and biological evaluation of C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors","volume":"24","author":"Kim","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116417_bib33","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.bmc.2019.02.040","article-title":"Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents","volume":"27","author":"Kim","year":"2019","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:34:29Z","timestamp":1717234469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424002976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":33,"alternative-id":["S0223523424002976"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116417","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel diaryl substituted isoquinolin-1(2H)-one derivatives as hypoxia-inducible factor-1 signaling inhibitors for the treatment of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116417"}}